U.S. Markets closed

MICT, Inc. (MICT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.8700+0.7900 (+25.65%)
At close: 4:00PM EDT

3.8600 -0.01 (-0.26%)
After hours: 4:04PM EDT

Full screen
Loading interactive chart...
  • MICT Subsidiary Micronet Receives Initial Orders from One of the Largest Automotive OEM Truck Manufacturers in Europe
    PR Newswire

    MICT Subsidiary Micronet Receives Initial Orders from One of the Largest Automotive OEM Truck Manufacturers in Europe

    MICT, Inc. (Nasdaq: MICT), (the "Company"), announced today that its majority-owned subsidiary Micronet Ltd. ("Micronet") has received initial orders from a leading European truck manufacturer for units of its new SmartHub and SmartTab 8 tablets. These are the first orders received from this customer, a very significant Original Equipment Manufacturer (OEM) with tens of thousands of trucks manufactured and sold worldwide.

  • MICT Obtains Stockholder Approval of Certain Stock Issuances and the Increase of its Authorized Share Capital as Pertains to its Recent Acquisition of Global Fintech Holdings
    PR Newswire

    MICT Obtains Stockholder Approval of Certain Stock Issuances and the Increase of its Authorized Share Capital as Pertains to its Recent Acquisition of Global Fintech Holdings

    MICT, Inc. (Nasdaq: MICT) ("MICT" or the "Company") announced today that it has successfully completed its special stockholders meeting.

  • Benzinga

    Benzinga's Top Upgrades, Downgrades For August 25, 2020

    Upgrades * According to Telsey Advisory Group, the prior rating for Burlington Stores Inc (NYSE: BURL) was changed from Market Perform to Outperform. In the first quarter, Burlington Stores showed an EPS of $4.76, compared to $1.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $250.89 and a 52-week-low of $105.67. Burlington Stores closed at $194.23 at the end of the last trading period. * According to Citigroup, the prior rating for Gap Inc (NYSE: GPS) was changed from Neutral to Buy. For the first quarter, Gap had an EPS of $2.51, compared to year-ago quarter EPS of $0.24. The current stock performance of Gap shows a 52-week-high of $19.86 and a 52-week-low of $5.26. Moreover, at the end of the last trading period, the closing price was at $15.51. * For L Brands Inc (NYSE: LB), MKM Partners upgraded the previous rating of Neutral to the current rating Buy. For the second quarter, L Brands had an EPS of $0.25, compared to year-ago quarter EPS of $0.24. The current stock performance of L Brands shows a 52-week-high of $31.33 and a 52-week-low of $8.00. Moreover, at the end of the last trading period, the closing price was at $29.63. * According to UBS, the prior rating for NIO Inc (NYSE: NIO) was changed from Sell to Neutral. NIO earned $0.15 in the second quarter, compared to $0.45 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.44 and a 52-week-low of $1.19. NIO closed at $14.97 at the end of the last trading period. * For Starbucks Corp (NASDAQ: SBUX), Stifel upgraded the previous rating of Hold to the current rating Buy. For the third quarter, Starbucks had an EPS of $0.46, compared to year-ago quarter EPS of $0.78. The stock has a 52-week-high of $98.14 and a 52-week-low of $50.02. At the end of the last trading period, Starbucks closed at $78.68. * For Crocs Inc (NASDAQ: CROX), B. Riley FBR upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Crocs showed an EPS of $1.01, compared to $0.59 from the year-ago quarter. The current stock performance of Crocs shows a 52-week-high of $43.79 and a 52-week-low of $8.40. Moreover, at the end of the last trading period, the closing price was at $39.34. * According to CIBC, the prior rating for Mercer International Inc (NASDAQ: MERC) was changed from Neutral to Outperformer. Mercer International earned $0.13 in the second quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $13.62 and a 52-week-low of $6.42. At the end of the last trading period, Mercer International closed at $8.00. Downgrades * For Portland General Electric Co (NYSE: POR), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. Portland General Electric earned $0.43 in the second quarter, compared to $0.28 in the year-ago quarter. The stock has a 52-week-high of $63.08 and a 52-week-low of $37.83. At the end of the last trading period, Portland General Electric closed at $41.96. * Jefferies downgraded the previous rating for Galapagos NV (NASDAQ: GLPG) from Buy to Hold. In the second quarter, Galapagos showed an EPS of $1.95, compared to $0.96 from the year-ago quarter. The stock has a 52-week-high of $274.03 and a 52-week-low of $112.00. At the end of the last trading period, Galapagos closed at $134.83. * According to Atlantic Equities, the prior rating for Nutrien Ltd (NYSE: NTR) was changed from Overweight to Neutral. For the second quarter, Nutrien had an EPS of $1.45, compared to year-ago quarter EPS of $1.58. The current stock performance of Nutrien shows a 52-week-high of $52.41 and a 52-week-low of $23.85. Moreover, at the end of the last trading period, the closing price was at $39.06. * Stifel downgraded the previous rating for Old Dominion Freight Line Inc (NASDAQ: ODFL) from Hold to Sell. Old Dominion Freight Line earned $1.25 in the second quarter, compared to $2.16 in the year-ago quarter. At the moment, the stock has a 52-week-high of $227.21 and a 52-week-low of $119.01. Old Dominion Freight Line closed at $198.83 at the end of the last trading period. * For Momenta Pharmaceuticals Inc (NASDAQ: MNTA), HC Wainwright & Co. downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Momenta Pharmaceuticals showed an EPS of $0.48, compared to $1.16 from the year-ago quarter. The current stock performance of Momenta Pharmaceuticals shows a 52-week-high of $52.32 and a 52-week-low of $11.91. Moreover, at the end of the last trading period, the closing price was at $52.15. Initiations * Aegis Capital initiated coverage on MICT Inc (NASDAQ: MICT) with a Buy rating. The price target for MICT is set to $6.00. In the second quarter, MICT showed an EPS of $0.00, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.45 and a 52-week-low of $0.38. MICT closed at $3.59 at the end of the last trading period. * Truist Securities initiated coverage on Forte Biosciences Inc (NASDAQ: FBRX) with a Buy rating. The price target for Forte Biosciences is set to $70.00. The stock has a 52-week-high of $25.49 and a 52-week-low of $17.90. At the end of the last trading period, Forte Biosciences closed at $24.70. * With a current rating of Overweight, Wells Fargo initiated coverage on NXP Semiconductors NV (NASDAQ: NXPI). The price target seems to have been set at $145.00 for NXP Semiconductors. In the second quarter, NXP Semiconductors showed an EPS of $0.91, compared to $1.91 from the year-ago quarter. The current stock performance of NXP Semiconductors shows a 52-week-high of $139.59 and a 52-week-low of $58.41. Moreover, at the end of the last trading period, the closing price was at $123.78. * Ladenburg Thalmann initiated coverage on Synchronoss Technologies Inc (NASDAQ: SNCR) with a Buy rating. The price target for Synchronoss Technologies is set to $8.00. In the second quarter, Synchronoss Technologies showed an EPS of $0.16, compared to $0.28 from the year-ago quarter. The current stock performance of Synchronoss Technologies shows a 52-week-high of $8.78 and a 52-week-low of $2.17. Moreover, at the end of the last trading period, the closing price was at $4.39. * With a current rating of Buy, B of A Securities initiated coverage on Vasta Platform Ltd (NASDAQ: VSTA). The price target seems to have been set at $21.50 for Vasta Platform. Vasta Platform earned $0.12 in the second quarter. At the moment, the stock has a 52-week-high of $19.43 and a 52-week-low of $15.31. Vasta Platform closed at $16.02 at the end of the last trading period. * Stifel initiated coverage on Vital Farms Inc (NASDAQ: VITL) with a Buy rating. The price target for Vital Farms is set to $43.00. The stock has a 52-week-high of $43.30 and a 52-week-low of $34.51. At the end of the last trading period, Vital Farms closed at $39.38. * With a current rating of Outperform, Raymond James initiated coverage on ACADIA Pharmaceuticals Inc (NASDAQ: ACAD). The price target seems to have been set at $65.00 for ACADIA Pharmaceuticals. ACADIA Pharmaceuticals earned $0.27 in the second quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $58.72 and a 52-week-low of $23.77. At the end of the last trading period, ACADIA Pharmaceuticals closed at $38.00. * Raymond James initiated coverage on argenx SE (NASDAQ: ARGX) with an Outperform rating. The price target for argenx is set to $257.00. For the second quarter, argenx had an EPS of $3.15, compared to year-ago quarter EPS of $1.12. The current stock performance of argenx shows a 52-week-high of $272.74 and a 52-week-low of $103.75. Moreover, at the end of the last trading period, the closing price was at $232.77. * 86 Research initiated coverage on Baozun Inc (NASDAQ: BZUN) with a Hold rating. The price target for Baozun is set to $43.00. In the second quarter, Baozun showed an EPS of $0.34, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $50.33 and a 52-week-low of $22.19. At the end of the last trading period, Baozun closed at $40.99. * Raymond James initiated coverage on Global Blood Therapeutics Inc (NASDAQ: GBT) with an Outperform rating. The price target for Global Blood Therapeutics is set to $115.00. For the second quarter, Global Blood Therapeutics had an EPS of $0.86, compared to year-ago quarter EPS of $1.01. The current stock performance of Global Blood Therapeutics shows a 52-week-high of $87.54 and a 52-week-low of $39.95. Moreover, at the end of the last trading period, the closing price was at $62.61. * For GW Pharmaceuticals PLC (NASDAQ: GWPH), Raymond James initiated coverage, by setting the current rating at Market Perform. GW Pharmaceuticals earned $0.02 in the third quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $151.35 and a 52-week-low of $67.98. At the end of the last trading period, GW Pharmaceuticals closed at $106.27. * Raymond James initiated coverage on Immunovant Inc (NASDAQ: IMVT) with an Outperform rating. The price target for Immunovant is set to $35.00. Immunovant earned $0.38 in the fourth quarter. The stock has a 52-week-high of $35.50 and a 52-week-low of $8.34. At the end of the last trading period, Immunovant closed at $33.48. * With a current rating of Buy, Deutsche Bank initiated coverage on Jack In The Box Inc (NASDAQ: JACK). The price target seems to have been set at $100.00 for Jack In The Box. In the third quarter, Jack In The Box showed an EPS of $1.37, compared to $1.07 from the year-ago quarter. The stock has a 52-week-high of $93.12 and a 52-week-low of $16.81. At the end of the last trading period, Jack In The Box closed at $83.36. * Raymond James initiated coverage on PTC Therapeutics Inc (NASDAQ: PTCT) with an Outperform rating. The price target for PTC Therapeutics is set to $63.00. For the second quarter, PTC Therapeutics had an EPS of $2.62, compared to year-ago quarter EPS of $0.75. The stock has a 52-week-high of $59.89 and a 52-week-low of $30.79. At the end of the last trading period, PTC Therapeutics closed at $48.04. * Raymond James initiated coverage on uniQure NV (NASDAQ: QURE) with a Strong Buy rating. The price target for uniQure is set to $75.00. For the second quarter, uniQure had an EPS of $0.96, compared to year-ago quarter EPS of $0.83. At the moment, the stock has a 52-week-high of $76.69 and a 52-week-low of $36.20. uniQure closed at $38.21 at the end of the last trading period. * Raymond James initiated coverage on Sarepta Therapeutics Inc (NASDAQ: SRPT) with an Outperform rating. The price target for Sarepta Therapeutics is set to $200.00. Sarepta Therapeutics earned $1.51 in the second quarter, compared to $0.83 in the year-ago quarter. The stock has a 52-week-high of $175.00 and a 52-week-low of $72.05. At the end of the last trading period, Sarepta Therapeutics closed at $141.20. * Morgan Stanley initiated coverage on Vasta Platform Ltd (NASDAQ: VSTA) with an Overweight rating. The price target for Vasta Platform is set to $20.00. Vasta Platform earned $0.12 in the second quarter. At the moment, the stock has a 52-week-high of $19.43 and a 52-week-low of $15.31. Vasta Platform closed at $16.02 at the end of the last trading period. * For Zogenix Inc (NASDAQ: ZGNX), Raymond James initiated coverage, by setting the current rating at Market Perform. In the second quarter, Zogenix showed an EPS of $0.96, compared to $0.89 from the year-ago quarter. The stock has a 52-week-high of $57.22 and a 52-week-low of $16.65. At the end of the last trading period, Zogenix closed at $22.93. * With a current rating of Buy, HC Wainwright & Co. initiated coverage on Kopin Corp (NASDAQ: KOPN). The price target seems to have been set at $2.00 for Kopin. Kopin earned $0.01 in the second quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Kopin shows a 52-week-high of $2.16 and a 52-week-low of $0.19. Moreover, at the end of the last trading period, the closing price was at $1.37. * Jefferies initiated coverage on Vital Farms Inc (NASDAQ: VITL) with a Buy rating. The price target for Vital Farms is set to $47.00. The stock has a 52-week-high of $43.30 and a 52-week-low of $34.51. At the end of the last trading period, Vital Farms closed at $39.38.See more from Benzinga * A Look Into Gartner's Debt * Domino's Pizza: Debt Insights * How Does Amgen's Debt Look?(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.